Antibe Therapeutics Announces Strategic Sale of Citagenix Subsidiary
TORONTO–(Organization WIRE)–Antibe Therapeutics Inc. (TSX: ATE, OTCQX: ATBPF), a clinical phase company leveraging its hydrogen sulfide platform to acquire following-era[…]
Read more